Unveiling the Future: Immuno-Oncology Assay Market to USD 5.77 BILLION IN 2024, forecast by 2028, Featuring a 12.5% CAGR – MarkNtel Advisors
Market Insights and Analysis: Immuno-Oncology Assay Market Overview and Projections (2023-2028) The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. Top leading companies in the Immuno-Oncology Assay Market includes: Agilent Technologies Inc., Aviva Systems …
